Trace Neuroscience Funding & Investors

South San Francisco, CA

Trace Neuroscience is a biopharmaceutical company that aims to extend the promise of genetic medicine to patients with neurodegenerative illnesses.

Total Amount Raised: $101,000,000

Trace Neuroscience Funding Rounds

Series A
$101,000,000
Nov 11, 2024
Series A Investors
Third Rock Ventures
Ra Capital Management
GV
Atlas Venture

Funding info provided by Diffbot.